Stay updated on High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-25T17:21:20.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-03-11T08:38:03.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-02-24T23:00:28.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-02-17T19:16:40.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-10T16:12:30.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T11:37:34.000Z thumbnail image

Stay in the know with updates to High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.